Pharmaceutical GMP readiness in South Korea
South Korea's Ministry of Food and Drug Safety (MFDS, formerly KFDA) regulates medicines under the Pharmaceutical Affairs Act and the Regulation on Safety of Medicinal Products. Korean GMP (KGMP) is aligned with PIC/S — MFDS became a PIC/S member in 2014 — and converges with EudraLex Vol 4. Marketing requires an authorized importer/manufacturer in Korea. Serialization of prescription drugs is mandatory through the Korea Pharmaceutical Information Service (KPIS). This guide covers the Korea-specific layer over an ICH Q10 PQS.
Regulator and legal basis
Licensing, release, and serialization
Documentation and language
Inspection style and common findings
A 90–180 day South Korea readiness path
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
MFDS — Ministry of Food and Drug Safety (식품의약품안전처) — South Korea's central regulatory authority for foods, pharmaceuticals, biologics, medical devices, cosmetics + quasi-drugs.
The international model for a Pharmaceutical Quality System covering the entire product lifecycle from development to discontinuation.
European equivalent of 21 CFR Part 11 — rules for computerised systems in GMP.
EU GMP Annex 1 (revision effective 25 August 2023, with full lyophilisation-section compliance from 25 August 2024) is the world's most influential sterile-manufacturing standard — adopted by EU, MHRA
The nine-letter mnemonic regulators use to grade your data integrity — and what every Part 11 audit really tests.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Frequently asked
Is Korea a PIC/S member?
How does KPIS differ from EU FMD?
Do we need a Korean QP?
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
- Global pharmaceutical GMP readiness — ICH, PIC/S, and country roll-up
- Australia pharmaceutical GMP readiness — TGA, PIC/S GMP, ARTG
- Brazil pharmaceutical GMP readiness — ANVISA, RDC 658/2022, CBPF, SNCM
- Canada pharmaceutical GMP readiness — Health Canada, FDR Div. 2, DEL
- China pharmaceutical GMP readiness — NMPA, Drug Administration Law, 2010 GMP
- EU pharmaceutical GMP readiness — EudraLex Vol 4, QP release, EU GDP
- GCC pharmaceutical GMP readiness — Saudi SFDA, GCC-DR, UAE MOHAP, RSD
- Global pharmaceutical GMP readiness — ICH, PIC/S, and country roll-up
